ATN 142: P3 and ATN 158: LifeSteps PrEP for Youth have re-opened after pausing enrollments in March due to the COVID-19 pandemic.
While enrollment and follow-up activities will be conducted remotely to protect the heath of participants and staff, ATN 142: P3 is enrolling for folks in Atlanta, Boston, the Bronx, Chapel Hill, Charlotte, Chicago, Houston, Philadelphia and Tampa. ATN 158: LifeSteps is enrolling participants who live in Atlanta, Boston, and Chicago.
P3 is a three arm, randomized-controlled trial (RCT) that will test the efficacy of a novel, theory-based mobile app that utilizes game mechanics and social networking features to improve PrEP adherence, retention in PrEP clinical care and PrEP persistence among young men who have sex with men (YMSM) and trans women who have sex with men (YTW), ages 16-24.
LifeSteps is an evidence-based HIV medication adherence intervention for individuals living with HIV developed by Safren et al. ATN 158: LifeSteps adapts this intervention for youth. The pilot randomized controlled trial (RCT) to assess feasibility, acceptability and preliminary efficacy of the LSPY compared to standard of PrEP care only to improve PrEP adherence.
See if you’re eligible to participate in one of these studies here!